SCHEMBL27165744

SCHEMBL27165744

CN(C)C(=O)c1cccc(Nc2nc3[nH]c4ccncc4c3c3ccc(C(=O)O)cc23)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 14/20 0.49
▸ CSNK2A2 P19784 11/20 0.48
▸ CSNK2B P67870 10/20 0.48
▸ PIM1 P11309 2/20 0.48
▸ PIM2 Q9P1W9 2/20 0.48
▸ CHEK1 O14757 1/20 0.47
▸ GAK O14976 1/20 0.47
▸ DAPK3 O43293 1/20 0.47
▸ DYRK3 O43781 1/20 0.47
▸ ULK1 O75385 1/20 0.47
▸ STK10 O94804 1/20 0.47
▸ CCNB2 O95067 1/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ CCNB1 P14635 1/20 0.47
▸ PHKG2 P15735 1/20 0.47
▸ CCNE1 P24864 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ CSNK1A1 P48729 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27165751 0.89 CSNK2A1 (0.49) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165756 0.88 CSNK2A1 (0.64) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165755 0.86 CSNK2A1 (0.65) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165753 0.86 CSNK2A1 (0.52) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165757 0.86 CSNK2A1 (0.49) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165748 0.86 CSNK2A1 (0.66) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL31356294 0.85 EPHB4 (0.47) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165743 0.84 CSNK2A1 (0.47) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27074292 0.84 CSNK2A1 (0.54) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL27165752 0.83 CSNK2A1 (0.49) CSNK2A1CSNK2A2CSNK2BPIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11926629-B1 Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-03-12 — — US claimed
US-11926629-B1 Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11926629-B1 Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors CSNK2A3, CDK2, CSNK1G2 CSNK2A1 7/4885CSNK2A2 6/4885CSNK2B 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback